Recent work has indicated that photobiomodulation (PBM) may beneficially alter the pathological status of several neurological disorders, although the mechanism currently remains unclear. The current study was designed to investigate the beneficial effect of PBM on behavioral deficits and neurogenesis in a photothrombotic (PT) model of ischemic stroke in rats. From day 1 to day 7 after the establishment of PT model, 2-minute daily PBM (CW, 808 nm, 350 mW/cm 2 , total 294 J at scalp level) was applied on the infarct injury area (1.8 mm anterior to the bregma and 2.5 mm lateral from the midline). Rats received intraperitoneal injections of 5-bromodeoxyuridine (BrdU) twice daily (50 mg/kg) from day 2 to 8 post-stoke, and samples were collected at day 14. We demonstrated that PBM significantly attenuated behavioral deficits and infarct volume induced by PT stroke. Further investigation displayed that PBM remarkably enhanced neurogenesis and synaptogenesis, as evidenced by immunostaining of BrdU, Ki67, DCX, MAP2, spinophilin, and synaptophysin. Mechanistic studies suggested beneficial effects of PBM were accompanied by robust suppression of reactive gliosis and the production of pro-inflammatory cytokines. On the contrary, the release of anti-inflammatory cytokines, cytochrome c oxidase activity and ATP production in peri-infarct regions were elevated following PBM treatment. Intriguingly, PBM could effectively switch an M1 microglial phenotype to an anti-inflammatory M2 phenotype. Our novel findings indicated that PBM is capable of promoting neurogenesis after ischemic stroke. The underlying mechanisms may rely on: 1) promotion of proliferation and differentiation of internal neuroprogenitor cells in the peri-infarct zone; 2) improvement of the neuronal microenvironment by altering inflammatory status and promoting mitochondrial function. These findings provide strong support for the promising therapeutic effect of PBM on neuronal repair following ischemic stroke.
Introduction
Stroke is considered to be the second leading cause of death, constituting a substantial economic burden for families and society (Ozturk, 2014) . Ischemic stroke, the most common form of stroke, is induced by the occlusion of the cerebral vasculature, causing irreversible tissue infarction and abnormal cellular death (Andrabi et al., 2017) . The photothrombotic stroke (PT) model is widely used as an experimental stroke model that simulates stroke conditions in humans by photothrombotic occlusion of cerebral microvessels (Pevsner et al., 2001; Schmidt et al., 2012) . In this model, focal illumination of the exposed skull proceeds after administration of the photoactive dye, rose bengal. Illumination triggers a photochemical reaction produces reactive singlet oxygen that damages the vascular endothelium, generating a thrombotic lesion characterized by a necrotic core surrounded by a well-defined peri-infarct penumbral region consisting of surviving, but damaged, tissue. The size and the location of this lesion can be easily modulated by the intensity, the duration and the location of light delivery in concise, reproducible manner with a high rate of survival compared to other stroke models (Watson et al., 1985) . In this process, local thrombosis is followed by free radical formation, disturbance of endothelial function, mitochondrial dysfunction, inflammatory response, neuronal injury, and subsequent behavioral deficits (Braeuninger and Kleinschnitz, 2009; Demyanenko et al., 2015; Schroeter et al., 2002; Shanina et al., 2005) .
Neurogenesis in the adult brain may be involved in targeting and repairing damaged tissue in ischemic stroke (Plane et al., 2004; Wang et al., 2017) , and the long-term survival of these nascent neurons plays a critical role in endogenous neurogenesis. Unfortunately, newly formed neurons struggle to survive long-term due to the prohibitive http://dx.doi.org/10.1016/j.expneurol.2017.10.013 Received 27 July 2017; Received in revised form 27 September 2017; Accepted 17 October 2017 properties of the post-stroke local microenvironment, indicating that neurogenesis after stroke cannot fully perform its self-repair process in the presence of certain maladaptive endogenous factors (Thored et al., 2006; Wang et al., 2015) . The inflammatory response is one facet of this deleterious microenvironment, and plays an important role in the pathological features of ischemic stroke. Brain injury activates inflammatory signaling and sets off a constellation of biochemical and molecular events that can culminate in neuronal cell death. Giannakopoulou et al. found that long-term inflammation in the brain could induce neurogenesis giving concession to gliogenesis (Giannakopoulou et al., 2017) . Neuroinflammation is characterized by activation of glial cells after ischemic stroke and is accompanied by the release of proinflammatory cytokines (Kim et al., 2014; Kreutzberg, 1996) . There are two major phenotypes of activated microglia which respond to brain injuries: the M1 "proinflammatory" phenotype and the M2 "anti-inflammatory" phenotype. Previous studies, including our own, found that transformation between the two phenotypes of microglial polarization could confer benefits in neurodegenerative disorders (Hu et al., 2012; Lu et al., 2017a) .
In addition to inflammation, mitochondrial dysfunction is another well-established factor in ischemia, owing to the key role of mitochondria in ATP production, Ca 2 + homeostasis, the generation of reactive oxygen species (ROS), and modulation of apoptosis (Zuo et al., 2016) . It has been reported that mitochondrial homeostasis and highenergy utility of neurons contributes to neuronal resistance to ischemia (Zuo et al., 2016) . The morphology and permeability of mitochondria are affected by ischemic challenge, resulting in a loss of mitochondrial membrane potential and decreased ATP levels, contributing to neuronal injury and cell death (Landes and Martinou, 2011; Sharp et al., 2014) . Notably, recent studies suggested that mitochondrial dysfunction is linked to the inhibition of adult neurogenesis (Voloboueva and Giffard, 2011) . While numerous studies have focused on promoting a favorable microenvironment by treatment with exogenous factors Wang et al., 2017) , the neurogenic properties and side effects of these factors remain to be established. PBM therapy is a well-documented non-drug-based therapy that could yield beneficial effects in an organism's endogenous self-repair mechanisms (Eissa and Salih, 2017; Lu et al., 2017a) . Numerous studies have indicated that the positive effects conferred by PBM result from decreasing inflammation, alleviating oxidative stress, and improving mitochondrial function (Ferraresi et al., 2015; Hamblin, 2017; Huang et al., 2013; Thunshelle and Hamblin, 2016) . In addition, several studies indicated that PBM can upregulate brain derived neurotrophic factor, improve synaptogenesis, reduce long-term neurological deficits, and exert a positive effect on the differentiation of neural progenitor cells after experimental stroke, which suggested that PBM may have potential as a novel, non-invasive stroke treatment Xuan et al., 2015; Xuan et al., 2014) . In summary, we hypothesize that PBM can promote cortical neurogenesis by enhancing the proliferation and differentiation of neural progenitors in the peri-infarct zone, in part by improving the neuronal microenvironment.
Materials and methods

Experimental design and drug administration
Male Sprague-Dawley rats (200-250 g) were used in the present work. Animals were randomly divided into 3 groups: (a) Normal animals without PT stroke; (b) PT stroke group; (c) PT stroke animals with PBM. All animal procedures complied with the guidelines of Institutional Animal Care and Use Committees. A strict blind procedure and analysis were conducted in this study. The researchers conducting behavioral tests, microscopic imaging and other evaluations were blinded to the experimental groups. PT stroke model was carried as described in our previous study . Briefly, the rats were anesthetized with an intraperitoneal (ip) injection of sodium pentobarbital (50 mg/kg) and placed in a stereotactic frame. Rose Bengal dye (0.1 mg/g, ip) was administrated to the animals for 5 min before the exposure of the skull. The periosteum was then gently removed, then the skull was illuminated for 15 min positioned onto the skull 1.8 mm anterior to the bregma and 2.5 mm lateral from the midline with a 6 mm diameter cold white light beam from a fiber optic cable. During the process of surgical operation, animals were placed on a heating pad, and rectal temperature was maintained at 37 ± 0.5°C. Afterward, the skin was sutured using wound clips. For laser treatment, 2-min daily laser irradiation (808 nm, 25 mW/cm 2 at cerebral cortex tissue level, 350 mW/cm 2 on the scalp), as reported in our previous work (Lu et al., 2017b) , was applied using a Diode IR Laser System (808 M100, Dragon Lasers) on the infarct injury area from day 1 to 7. The device information was shown in Table 1 . All animals were restrained in a transparent DecapiCone (DCL-120, Braintree Scientific, Inc., MA, USA) for 2 min and returned to their home cage immediately after treatment. The only difference between animals in PT stroke group and PBM group is that the laser power was not turned on when PBMuntreated animals were secured under the fiber optic output. An experimental protocol is shown in Fig. 1 .
Tissue preparation
For sample preparation, rats were sacrificed under anesthesia on day 14 after PT stroke. After perfusion with ice-cold saline, the rats were decapitated and the whole brains were then quickly removed. Brains were postfixed in 4% paraformaldehyde (PFA) at 4°C overnight, and then cryoprotected with 30% sucrose. Afterwards, brains were immersed in OCT cryoprotectant and frozen overnight at − 80°C. A Cryostat (Leica RM2155, Nussloch, Germany) was used for cutting brain sections (25 μm). For homogenization of the brain, brain tissues from the peri-infarct regions and sham controls were dissected from the cortex and immediately frozen in liquid nitrogen. The tissues were homogenized as previously described . In brief, a motor-driven Teflon homogenizer was used for homogenization in icecold homogenization medium (50 mM HEPES, pH 7.4, 150 mM NaCl, 12 mM β-glycerophosphate, 1% Triton X-100) with inhibitors of proteases and enzymes (Thermo Scientific, Rockford, IL). For the total protein fractions, the homogenates were vigorously mixed for 20 min and centrifuged for 30 min at 12,000 ×g at 4°C. For mitochondrial and subcellular cytosolic fraction, tissue samples were homogenized in a buffer containing 10 mM HEPES (pH 7.9), 0.6% NP-40, 12 mM β-glycerophosphate with protease, and enzyme inhibitors. The homogenates were centrifuged for 20 min at 800 ×g, and the resulting supernatants were then centrifuged at 17,000 × g for 20 min at 4°C to yield cytosolic fractions in the supernatant and mitochondrial fractions in pellet. Protein concentrations were measured by Modified Lowry Protein Assay (Pierce, Rockford, IL).
5-Bromodeoxyuridine (BrdU) labeling
BrdU (5-bromodeoxyuridine, Carbosynth Ltd) was used to label proliferating cells. In the present study, 7 consecutive days of BrdU Yang et al. Experimental Neurology 299 (2018) 86-96 (50 mg/kg, ip) injections were performed every 12 h from day 2 after PT stroke.
Infarct volume assessment
Infarct volume of different groups were measured by Cresyl violet staining. In brief, the selected brain sections were stained with 0.01% (w/v) cresyl violet for 10 min, followed by graded ethanol dehydration. The images of brain sections were acquired by AxioVision microscope system (Carl Zeiss, Germany). Image J (NIH) was applied to quantify the mean infarct area of each brain section. Infarct volume was calculated by the percentage of the total volume of the contralateral hemisphere per group .
Immunofluorescence staining and confocal microscopy
Immunofluorescence staining was performed as previously described by our laboratory (Lu et al., 2017b) . In brief, coronal brain sections (25 μm) were incubated with buffer containing 10% normal donkey serum and 0.1% Triton X-100 for 1 h at room temperature followed by incubation with the corresponding primary antibodies in the same buffer overnight at 4°C. The following primary antibodies were used: anti-BrdU, Ki67 (DSHB);anti-NeuN, MAP2, DCX (Santa Cruz);anti-synaptophysin, spinophilin (Abcam); anti-Iba1 and GFAP (Proteintech Group). After incubation with primary antibodies, the brain sections were washed three times at room temperature followed by incubation with proper secondary antibodies (Thermo Fisher Scientific) for 1 h at room temperature. Sections were then washed with PBS, mounted with water-based mounting medium, and coverslipped in Vectashield mounting medium with DAPI (Vector Laboratories). LSM510 Meta confocal laser microscope (Carl Zeiss) was used to capture the fluorescence images. The imaging areas were chosen from the peri-infarct penumbral region beneath the infarct surface for comparison of immunofluorescent intensity between groups. For quantitative analyses, the number of NeuN-positive cells per 150 μm length in the peri-infarct zone was counted in 4-5 areas selected on each slice. 3-4 slices (50 μm apart) were chosen from each rat.
Mitochondrial cytochrome C oxidase (CCO) activity
As described previously , CCO activity was measured by an activity assay kit (ab109911; Abcam Inc.) using mitochondrial fractions. Briefly, the fractions were loaded in microtitre plate for 3 h at room temperature. After washing twice with provided solution 1, assay solution was added to each well and the mitochondrial cytochrome C oxidase activity was measured at 550 nm absorbance (Bio-Rad Benchmark Plus, Microplate Spectrophotometer). The data of relative CCO activity were quantified as percentage changes versus sham group.
Quantification of total ATP content
As previously described by our lab, an ATP quantification kit (Lu et al., 2017b) , a kit ENLITEN® rLuciferase/Luciferin Reagent (FF2021, Promega, Madison, WI) was used to measure the level of ATP. Protein samples (30 μg) from total protein fractions were diluted in 100 μL of reconstituted rL/L reagent buffer (luciferase, D-luciferin, Tris-acetate buffer (pH 7.75), EDTA, magnesium acetate, bovine serum albumin, and dithiothreitol). Light emission from the reaction was examined in a standard microplate luminometer (PE Applied Biosystems) at 10-s intervals. The "background blank" was prepared, containing rL/L reagent and homogenization buffer, and the relative light units from "background blank" were subtracted from the sample light output in the assay. An ATP standard curve was used to determine the values of ATP, and the data of relative total ATP content were present as percentage changes versus sham group.
Pro-inflammatory cytokines assay
Indirect Enzyme-Linked-Immunosorbent-Assay (ELISA) was used to detect the levels of pro-inflammatory cytokines in each group (Lu et al., 2017a) . Primary antibody sources were as follows: anti-IL-4, IL-10, IL-6, TNF-α (Proteintech Group), and IL-18 (Santa Cruz). The levels of proinflammatory cytokines were measured as the optical density at 450 nm on a spectrophotometer (Bio-Rad), and the values were calculated and presented as percentage changes versus sham group.
Western blotting analysis
Western blotting was performed as our previous described (Zhang et al., 2009 ). In brief, proteins (50 μg) were separated on sodium dodecyl sulfate-poly-acrylamide gel electrophoresis (SDS-PAGE) and transferred to PVDF membrane. PVDF membranes were then blocked and incubated with appropriate primary antibody at 4°C overnight. Primary antibody sources include: anti-CD32, CD86, iNOS, ARG, TGF-β, CD206, and β-actin from Proteintech Group. After 3 washes, membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 h at room temperature. The bound proteins were then captured on a digital imaging system and analyzed by Image J analysis software (Version 1.49; NIH, USA). PT model was induced on day 0, and on days 1 through 7, rats were treated with PBM (2-min daily). BrdU (50 mg/kg, ip) was injected two times daily on days 2 through 8. Behavioral deficits were evaluated on days 1, 7 and 13. Rats were sacrificed on day 14, and whole brains were extracted and prepared for further analysis.
Cylinder test and adhesive test
The cylinder test was used to evaluate the effect of PBM on the asymmetric forelimb preference . It was performed on days 1, 7 and 13 after the establishment of the PT stroke model. The device employed in this test was a transparent glass cylinder (diameter: 10 cm; height: 15 cm). In this cylinder, the rats were allowed to contact with the side of the cylinder with its left or right forelimb for 2 min. During this test, researcher counted the number of contacts between left or right paws and the wall of the transparent glass. Contralateral paw use was calculated according to the following formula: score = (contralateral paw use/total paw use) × 100. In addition to this behavioral tests, the adhesive removal test was performed to measure somatosensory deficits on days 1, 7 and 13 after PT stroke. In this test, the experimenter put a small adhesive strip (0.35 × 0.45 cm) on the front paw of the rats and then returned the animal to an empty cage. The maximum recorded time spent on removing the adhesive tape was 2 min.
Statistical analysis
Statistical analysis was performed using one-way or two-way analysis of variance (ANOVA), followed by Student-Newman-Keuls posthoc tests with SigmaStat 3.5 software to determine group differences. To determine the differences between normal control group and other groups, Dunnett's test was performed for post-hoc analyses after ANOVA. A Student's t-test was adopted when only two groups were compared. Statistical significance was accepted at the 95% confidence level (P < 0.05). Data were expressed as means ± SE.
Results
PBM significantly alleviates behavioral deficits after PT stroke
To investigate the effect of PBM on alleviating behavioral changes after PT stroke, we utilized the cylinder test, a behavioral test commonly applied to measure spontaneous forelimb use, on days 1, 7 and 13 after PT stroke. As shown in Fig. 2A , cylinder test results revealed that PT rats displayed a significant decrease in relative paw use contralateral to the damaged hemisphere, as compared to sham rats. Interestingly, PT stroke animals that underwent PBM displayed significant improvement in relative contralateral paw use compared with those without PBM. In addition, the adhesive test was performed to assess forepaw somatosensory activity. As shown in Fig. 2B , the time spent removing the adhesive tape was significantly increased in animals that underwent PT stroke compared to sham, indicating an impaired somatosensory cortex function. Notably, this behavioral deficit was significantly improved by PBM compared with PT group animals.
3.2. PBM decreases cortical infarct size after PT stroke and increases the number of surviving neurons after PT stroke Next, we tested the effect of PBM on cortical infarct size and neuronal survival after PT. In the current work, the right somatosensory cortex (the dark area in Fig. 3A ) was damaged by induction of the PT stroke model. To investigate the effect of PBM on the size of cortical infarct, coronal sections were collected for staining. As shown in Fig. 3B  (a-c, and g ), PT stroke generated an infarct injury in the sensorimotor, the size of which was significantly decreased in the animals with PBM, suggesting that PBM has the ability to repair the infarct injury after PT stroke. Sham animals did not have any sign of cortical infarct, as expected. To corroborate these findings, brain sections were immunostained for detection of surviving neurons using a mouse antiNeuN antibody. As shown in Fig. 3B (d-f, and h ), the number of NeuN positive cells in cortex from rats that underwent PT stroke demonstrated a significant loss compared with normal animals, and this effect was significantly reversed by PBM.
3.3. PBM treatment significantly inhibits PT stroke-induced dendritic and synaptic injury MAP2, a widely used neuronal dendritic marker, is a sensitive and early indicator for the assessment of neuronal injury (Kitagawa et al., 1989) . We next investigated the expression of MAP2 in the cortex. As shown in Fig. 4A (a-c) and Fig. 4B (a) , confocal microscopy and quantitative analyses demonstrated that the expression of MAP2 was significantly decreased in PT group compared with sham group, and this effect was significantly reversed by PBM. The expressions of synaptic proteins were further measured to determine the potential effects of PBM. As shown in Fig. 4A (d-i) and Fig. 4B (b, c) , PT animals displayed decreased expressions of spinophilin (a postsynaptic marker) and synaptophysin (a presynaptic marker) that were significantly elevated in PBM treated animals, indicating that PBM provided effective protection against stroke-induced synaptic injury.
PBM enhances cortical neurogenesis in PT stroke rats
To investigate whether PBM could promote neurogenesis after PT stroke, brain sections were labeled with BrdU, Ki67 and DCX. As shown in Fig. 5A (a-c) , representative confocal images revealed BrdU-positive cells were present in the cortex and concentrated in the peri-infarct region in PT group animals. When compared to the immunoactivity of BrdU in PT group, immunoactivity in PBM group was markedly increased. Fig. 5A presents the immunoreactivity of Ki67 (d-f) and DCX (g-i) revealing that PBM markedly increased the levels of Ki67 (a marker for stem cell proliferation) and DCX (a pre-mature neuronal marker and differentiation marker), as compared to PT group. Quantitative evaluation of BrdU, Ki67 and DCX were performed and shown in Fig. 5B . Intriguingly, as indicated in Fig. 5C (a) , we observed that the increased neurogenesis was restricted to a regions (around 1.00 mm wide belt) beneath the infarct zone surface. As shown in Fig. 5C (b-c) , PBM could significantly increase the quantity of BrdUpositive cells without changing the size of neurogenesis area at the examined time point (day 14 after PT). To distinguish whether this neurogenesis occurred directly in the cortex or occurred in the dentate gyrus (DG) or subventricular zone (SVZ), where the newly formed cells migrate to the injured cortex, confocal images of those three markers from DG and SVZ were also acquired. Interestingly, we did not find significant differences from those areas between groups (data not shown). These data clearly display that PBM could enhance cortical neurogenesis and maintain the survival of these newly formed neurons, as evidenced by significantly higher levels of neurogenesis markers after PBM in cortex.
PBM rescues PT-induced mitochondrial dysfunction
Our previous work has indicated that PBM could restore mitochondrial dynamics, suppress collapse of mitochondrial membrane potential, promote CCO activity, and increase synthesis of ATP in a streptozotocin-induced sporadic Alzheimer's Disease rat model (Lu et al., 2017b) . In this study, we investigated whether PBM can rescue PT-induced mitochondrial dysfunction. As shown in Fig. 6A , PT stroke significantly decreased CCO activity compared with that of normal animals, an effect ameliorated with PBM. To determine whether PBM could affect the level of cortical ATP production, we further measured the level of ATP. Our results showed that cortical ATP levels were significantly diminished in PT group compared with sham group. In contrast, the level of ATP in PBM group was significantly elevated in comparison with PT-induced stroke groups (Fig. 6B) . These results suggested that PBM is effective in restoring mitochondria function by improving CCO activity and enhancing ATP synthesis in this PT stroke model.
PBM suppresses PT stroke-induced gliosis and inflammation, and alternates the phenotype of microglial polarization
We next investigated the effect of PBM on inflammatory response in stroke, as neuroinflammation has been well documented to play an important role in the pathogenesis of stroke Couch et al., 2017) . As shown in Fig. 7A and B, representative microscopy and quantification analysis from peri-infarct cortex showed that the expressions of GFAP and Iba-1 in PT group were significantly elevated compared to the sham animals. However, the expressions of GFAP and Iba-1 in PBM treatment group were significantly decreased compared to the PT stroke animals. To determine the effect of PBM on inflammatory response, we measured the levels of specific pro-inflammatory cytokines and anti-inflammatory cytokines in the cortex protein. As shown in Fig. 8A (a-c) , ELISA assays indicated that the elevated levels of proinflammatory cytokines IL-6, TNF-α and IL-18 after PT stroke were significantly ameliorated by PBM treatment. Intriguingly, the levels of anti-inflammatory cytokines, IL-1 and IL-10, were effectively elevated in PT animals treated with PBM compares with PT control group (Fig. 8B) .
There are two different inflammation-related phenotypes of activated microglia, termed the M1 "pro-inflammatory" phenotype and the M2 "anti-inflammatory" phenotype, which are related to producing pro-inflammatory factors and anti-inflammatory factors respectively (Durafourt et al., 2012; Lu et al., 2017a) . We then investigated the effect of PBM on the transformation of two phenotypes of microglial polarization. As shown in Fig. 9A , Western blot analysis of M1 markers indicated a robust elevation of the expressions of CD32, CD86 and iNOS in the PT group compared with sham, an effect that was substantially mitigated by PBM treatment. Interestingly, the expressions of M2 markers (ARG1, TGF-β, CD206) in PBM groups were significantly elevated, as compared with PT group (Fig. 9B) , demonstrating PBM treatment could transform microglial polarization from the M1 "proinflammatory" phenotype to the M2 "anti-inflammatory" phenotype. 
Discussion
Using a well-established photothrombosis-induced ischemic stroke model, the current study first demonstrated the beneficial effect of PBM in promoting cortical neurogenesis. The key findings are that PBM markedly improved post-stroke cortical neurogenesis, and this effect was correlated with the improvement of the neuronal microenvironment and the proliferation and differentiation of neural progenitor cells in the peri-infarct zone. The underlying mechanism of PBM responsible for supporting neurogenesis and alleviating behavioral deficits may be related to the findings as illustrated in the current study: 1) restoration of mitochondrial function and providing the nascent neurons with more ATP, 2) suppression of reactive gliosis and neuroinflammation, 3) alteration of the microglial phenotype, as well as 4) enhancement of neural progenitor proliferation and differentiation. These findings indicate that PBM may provide functional recovery and promote neural repair following ischemic stroke, positioning it as a promising therapeutic option in stroke management.
A previous study suggested that the generation of new neurons in the adult brain primarily occurs in the subventricular zone (SVZ) and subgranular zone (SGZ) of the dentate gyrus, and that this process is stimulated in brain injury conditions (Jin et al., 2001; Liu et al., 1998; Parent et al., 1997; Shimazaki and Okano, 2008) . Numerous evidence over the years has suggested that neurogenesis also occurred in the cortex (Gu et al., 2000; Jiang et al., 2001) , and this cortical neurogenesis has been considered as a potential therapeutic target in stroke treatment. While numerous evidence indicated that though the adult brain may repair itself by neurogenesis after stroke, this effect is shortlived, unfortunately, as the ability of self-repair was dampened due to the harsh local microenvironment (Arvidsson et al., 2002; Thored et al., 2006) . In the process of cellular proliferation, the cellular responses are governed by numerous and complex chemical and physical cues from their surrounding microenvironment (Kawamura et al., 2016) . A great number of studies have investigated the effect of the microenvironment on cell proliferation. Studies found the creation of an optimal combination of cells with an appropriate microenvironment was important for promoting proliferation, migration, and differentiation (Kawamura et al., 2016; Trensz et al., 2016) . In our study, we proposed that the effect of PBM on neurogenesis can be attributed to its improvement of the microenvironment which neurogenesis depends on for proper Fig. 4 . Effect of PBM on PT stroke-induced neuronal injury in the infarct cortical region 14 days after PT stroke. (A) Typical staining of MAP2 in healthy control animals (a), animals that underwent PT stroke without (b) or with PBM treatment (c). Representative confocal microscopy images of synaptophysin (d-f) and spinophilin (g-i) were taken from the infarct cortical region 14 days after PT stroke. (B) The fluorescent intensity of MAP2 (a), synaptophysin (b) and spinophilin (c) were quantified using Image J analysis software and expressed as percentage changes versus the respective control group. (C) The region in which neurogenesis is illustrated (a) and representative images from PT (b) and PBM treated rats (c) are displayed. All data are expressed as mean ± SE (n = 4-5). *P < 0.05 versus sham, # P < 0.05 versus PT. Scale bar = 10 μm.
health, and the promotion of proliferation and differentiation of internal stem cells in the peri-infarct zone.
Findings from previous studies indicated that the milieu of inflammatory cytokines released by a cell is an important factor in creating an appropriate microenvironment for tissue repair (Kawamura et al., 2016; Yu et al., 2014) . The inflammatory response plays an important role in the pathological process of ischemic stroke, and attenuated post-insult levels of pro-inflammatory cytokines may confer a protective effect to the brain (Esenwa and Elkind, 2016; Sieber et al., 2011) . Cerebral ischemia is also usually accompanied with the release of pro-inflammatory cytokines (e.g. IL-1β, IL-6, TNF-α and IL-18), which initiates a serious neuroinflammatory attack to the brain (Winklewski et al., 2014; Yan et al., 2015) . Evidence has demonstrated that PBM can decrease inflammation in diabetes, lung inflammation, skeletal muscle inflammation and crush injury to the rat sciatic nerve (Alcantara et al., 2013; Fukuoka et al., 2017; Mantineo et al., 2014; Miranda da Silva et al., 2015) . Our previous study about the beneficial effect of PBM on AD suggested PBM can inhibit Aβ-induced reactive gliosis and neuroinflammation (Lu et al., 2017b) . Furthermore, the effect of PBM on stroke has been widely investigated. Studies found PBM could improve behavioral outcomes in an embolic stroke model, middle cerebral artery occlusion (MCAO) model and in addition, there is some evidence demonstrating the beneficial effect of PBM on acute ischemic stroke in humans Lampl et al., 2007; Lapchak et al., 2004; Zivin et al., 2009 ). In our study, we found PBM could decrease the level of reactive gliosis and pro-inflammatory cytokine release induced by PT stroke. Notably, we found PBM can promote the transformation from the M1 "pro-inflammatory" phenotype to the M2 "anti-inflammatory" phenotype. Previous studies have indicated that M1 microglia primarily release pro-inflammatory cytokines and M2 microglia primarily secrete anti-inflammatory factors which was in accordance with the results of the levels of inflammatory factors in our were taken from the cortical peri-infarct region on day 14 after PT stroke. (B) The immunoactivity associated with BrdU, Ki67 and DCX in each group were further quantified and shown in arbitrary unit (a, b and c respectively). (C) The increased neurogenesis was restricted to a regions (around 1.00 mm wide belt) beneath the infarct zone surface with the representative confocal microscopy of Brdu staining (a-c). All data are expressed as mean ± SE (n = 4-5). *P < 0.05 versus sham, # P < 0.05 versus PT. Scale bar = 20 μm. L. Yang et al. Experimental Neurology 299 (2018) 86-96 study (Barakat and Redzic, 2016; Choi et al., 2017; Yang et al., 2017; Yuan et al., 2017) . Those results mentioned above indicated that the modulatory actions of PBM on gliosis, release of pro-/anti-inflammatory and transformation between the two phenotypes of activated microglia may contribute to decrease inflammatory damage and improve the neuronal microenvironment making it more amenable to neuronal health. In addition to the inflammatory response, mitochondrial dysfunction contributes to the harsh microenvironment after stroke (Lapchak and Boitano, 2016; Miao et al., 2016; Narne et al., 2017) . Evidence from numerous studies has indicated that depletion of ATP during stroke may play an essential role in the development of extensive cell death and brain injury (Dirnagl et al., 1999; Li et al., 2016; Moskowitz et al., 2010) . Mitochondria are a major target of inflammation-related injury. It has been suggested that increased levels of inflammatory cytokines and ROS can lead to the impairment of mitochondrial function in neuroprogenitor cells (Voloboueva and Giffard, 2011) . Mitochondria play a central role in the differentiation of progenitor cells into mature neurons and, as such, mitochondrial impairment can suppress this critical differentiation (Bernstein and Bamburg, 2003; Voloboueva and Fig. 7 . PBM inhibits PT stroke-induced glial activation. (A) Representative confocal microscopy of GFAP (a-c) and Iba-1 (d-f) staining taken from the peri-infarct cortical region. (B) The fluorescent intensity of GFAP (a) and Iba-1(b) was quantified and expressed as percentage changes versus the respective control group. Values are expressed as mean ± SE (n = 4-5). *P < 0.05 versus sham, # P < 0.05 versus PT group. Giffard, 2011). In addition, it has been found that mitochondrial dysfunction can induce rapid mitochondrial membrane potential loss and subsequent neuronal death (Bolanos and Almeida, 2006; Voloboueva et al., 2007) . Depletion of mitochondrial DNA has been demonstrated to induce the death of neuroprogenitor cells within a short time, corroborating the detrimental impact of mitochondrial damage on the wellbeing of neuroprogenitor cells (Fike et al., 2009 ). Consistent with this, studies have demonstrated that the preservation of mitochondrial function can confer protection to neurons against inflammatory injury (Voloboueva et al., 2007) . The mechanisms behind this neuroprotection are multifactorial and not entirely elucidated, ranging from anti-inflammatory signaling pathways and attenuation of apoptotic factor release (Lu et al., 2017a; Zhao et al., 2016) . Preservation of ATP production has, likewise, been shown to play a critical role in neuronal survival Lu et al., 2017b) . Lapchak et al. found that elevation of ATP induced by PBM had a correlation with the improvement of behavioral deficit after embolic strokes (Lapchak and De Taboada, 2010) . Our previous work demonstrated PBM could rescue mitochondrial dysfunction and restore mitochondrial dynamics in STZinduced Alzheimer's disease (Lu et al., 2017b) . In this study, we measured the level of ATP from total protein fractions and found PT stroke could induce cortical ATP depletion and, which was in accordance with previous evidence Lapchak and De Taboada, 2010) , and, interestingly, this loss was rescued by PBM. Modulated by the effects of PBM, mitochondrial cytochrome c oxidase (CCO) enzyme plays a critical role in inhibition of ATP losses Eells et al., 2003) . CCO is an enzyme which works in the cellular respiratory chain and regulates the production of ATP via oxidative phosphorylation (Medeiros and Jennings, 2002) . The Cu A and Cu B complexes located in the center of CCO have been identified as the targets of PBM (Medeiros and Jennings, 2002) . In our study, we measured the activity of CCO 14 days after PT stroke and results revealed that the activity of CCO in the PT stroke group had a significant decrease as compared to sham rats. PBM treatment, however was able to recover this when compared with PT stroke animals. In line with our findings on ATP, increasing activity of CCO was correlated with improved production of ATP (Pastore et al., 1994) .
The effect of PBM on neuroprogenitor cells plays an important role in cortical neurogenesis. Previous studies indicated that PBM can increase neurogenesis by stimulating the proliferation, differentiation, and migration of neuroprogenitor cells in DG and SVZ, which is accompanied by increased levels of brain derived neurotrophic factor (BDNF) and synaptogenesis (Xuan et al., 2015; Xuan et al., 2014) . In our present work, the BrdU/DCX/Ki67-positive cells from DG and SVZ were not apparently observed, suggesting the PBM's effects is specific in the peri-infarct zone in this PT stroke model. Although more evidence is needed to demonstrate the role of neuroprogenitor cells in this selfrepair process, the presence of DCX and Ki67-positive cells in the periinfarct area suggested that neuroprogenitor cells stimulated by PBM may play an important role in this self-repair via enhancing cortical neurogenesis. Synaptogenesis has been shown to be increased by PBM in traumatic brain injury models in mice (Xuan et al., 2015) . In this study, the immunoactivity of spinophilin and synaptophysin were increased in an "expend" layer where neurogenesis was predominant, which suggested PBM can induce synaptogenesis between the newly formed neurons in the cortical area, although we cannot exclude the possibility that these increases in synaptic markers are partly from synaptogenesis of existing neurons.
Previous studies have indicated that several important parameters contribute to the biphasic dose response of PBM on tissue (DemidovaRice et al., 2007; Oron et al., 2001; Xuan et al., 2016) . Evidence suggests that a single dose can confer benefical effects on brain injury when applied at different time points Xuan et al., 2015; Xuan et al., 2016) . Other report have demonstrated that excessive repeated transcranial PBM therapy can induce neuroinflammation, nullifying its therapeutic action, which has led to numerous studies investigating the effect of single dose treatment strategy on stroke (Xuan et al., 2016) . It should be noted that we did not find apparent improvement induced by a single dose from the behavioral test results in this model (data not shown). However, several studies have observed the neuroprotective effect of multiple doses on different models (Lu et al., 2017b; Salehpour et al., 2017; Xuan et al., 2015; Xuan et al., 2014) . Therefore, in the present study, we have adapted a diode laser system by which the dose of PBM therapy was chosen based on our recent study as cortical dosage of 3 J per day using multiple doses (Lu et al., 2017b) . It has been indicated that the 13.3 J dose received by cortex was not able to induce cortical temperature increase and histopathological damage according previous study (Chen et al., 2013) . There are several excellent publications measuring the effect of different PBM parameters which suggest that the effect of PBM on animal may depend primarily on the total dose, the repetition regimen, wave modes, and wavelengths of laser (Ando et al., 2011; Wu et al., 2012; Xuan et al., 2016; Xuan et al., 2013) 
Conclusions
Our current study demonstrated PBM, a well-documented non-drug based therapy, could alleviate behavioral deficits and promote cortical neurogenesis in the PT stroke model. Furthermore, the most important findings in this work is that PBM can shift the phenotype of microglial polarization from the M1 "pro-inflammatory" phenotype to the M2 "anti-inflammatory" phenotype. Although further in-depth mechanistic investigation about the effects of PBM on neurogenesis are still needed, the results of our study demonstrate that PBM can improve cortical neurogenesis after stroke and can improve functional outcomes in adult rats. We believe that this non-invasive laser treatment paradigm can shine a new light on the investigation of neurogenesis in stroke.
